Patents by Inventor Shreekrishna M. Gadekar

Shreekrishna M. Gadekar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for reducing serum uric acid levels
    Patent number: 4052509
    Abstract: Novel pharmaceutical compositions containing as the active ingredient the compound 5-methyl-1-phenyl-2-(1H)-pyridone are described. Such compositions have been found to have a metabolic property which causes significant lowering of serum uric acid levels in humans and other mammals. The compositions containing 5-methyl-1-phenyl-2-(1H)-pyridone caused no irritation on oral administration or when applied to specific target tissues showed no significant irritation or other sequelae.
    Type: Grant
    Filed: May 14, 1976
    Date of Patent: October 4, 1977
    Assignee: Affiliated Medical Research, Inc.
    Inventor: Shreekrishna M. Gadekar
  • Method for reducing serum glucose levels
    Patent number: 4042699
    Abstract: Novel pharmaceutical compositions containing as the active ingredient the compound 5-methyl-1-phenyl-2-(1H)-pyridone are described. Such compositions have been found to have a metabolic property which causes significant lowering of serum glucose levels in humans and other mammals. The compositions containing 5-methyl-1-phenyl-2-(1H)-pyridone caused no irritation on oral administration or when applied to specific target tissues showed no significant irritation or other sequelae.
    Type: Grant
    Filed: May 14, 1976
    Date of Patent: August 16, 1977
    Assignee: Affiliated Medical Research, Inc.
    Inventor: Shreekrishna M. Gadekar
  • 5-Methyl-1-phenyl-2-(1H)-pyridone compositions and methods of use
    Patent number: 3974281
    Abstract: Novel analgesic, anti-pyretic, anti-inflammatory compositions containing as the active ingredient the compound, 5-methyl-1-phenyl-2-(1H)-pyridone are described. Such compositions have also been found to cause significant lowering of serum uric acid and glucose levels and to be effective in the treatment of a number of upper respiratory ailments in humans and other mammals. Skin conditions such as dermatitis and poison ivy are also alleviated by this agent. The compositions containing 5-methyl-1-phenyl-2-(1H)-pyridone caused no irritation on oral administration or when applied to specific target tissues showed no significant irritation or other sequelae.
    Type: Grant
    Filed: December 9, 1974
    Date of Patent: August 10, 1976
    Assignee: Affiliated Medical Research, Inc.
    Inventor: Shreekrishna M. Gadekar